// App-Quantinova.ai

P716 : The Impact of Fibrotic Extracellular Matrix on Patient-Derived Lung Tumor Organoids

Researchers

Presenter

  • A. L. Van Der Velden

Principal Investigators

  • P. T. Neilan

  • N. Dirks

  • E. Hoffman

  • J. Faber

  • D. J. Weiss

  • C. Kinsey

Medical Centers

  • University of Vermont, Burlington, VT, United States

  • Univ of Vermont/Hlth Sci Rsch Facility, Burlington, VT, United States

  • PCCM, University of Vermont Medical Center, Burlington, VT, United States

  • Pulmonary and Critical Care, University of Vermont College of Medicine, Burlington, VT, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

  • Lung Cancer

  • Solid malignancies

Biomarkers

  • Glutathione

  • Glutathione S-transferase P1

  • KRAS proto-oncogene, GTPase

Drug/Treatment

  • glutathione

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved